Hosted on MSN3d
EDX Medical develops new ‘super test’ for prostate cancer
According to EDX, the test studies the most comprehensive range of clinically validated prostate-related biomarkers currently ...
manilatimes1d
Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA
Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...
Science Media Centre3d
expert reaction to EDX medical press release giving topline findings on a new prostate cancer screening test
Scientists comment on a press release from EDX that gives findings on a new screening test for prostate cancer. Prof Derek Rosario, Consultant Urological Surgeon, Honorary Professor and Clinical ...